References
- Statens Serum InstitutCancerregisteret 2011, tal og analyse. [Cancer Registry 2011, Figures and Analysis] Available from: http://www.ssi.dk/Sundhedsdataogit/Registre/~/media/Indhold/DK%20-%20dansk/Sundhedsdata%20og%20it/NSF/Registre/Cancerregisteret/Cancerregisteret%202011.ashxAccessed April 22, 2013 Danish
- The Danish Colorectal Cancer GroupThe Danish Colorectal Cancer Group Guidelines 2012 Available from: http://www.dccg.dk/retningslinjer/indeks.html. DanishAccessed April 22, 2013
- AndreTBoniCMounedji-BoudiafLOxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerN Engl J Med20043502343235115175436
- HurwitzHFehrenbacherLNovotnyWBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerN Engl J Med20043502335234215175435
- MurthyVHKrumholzHMGrossCPParticipation in cancer clinical trials: race-, sex-, and age-based disparitiesJAMA20042912720272615187053
- Ministry of Health and PreventionHealth Care in Denmark, Copenhagen, Denmark, 2008 Available from: http://www.sum.dk/Aktuelt/Publikationer/~/media/Filer%20-%20Publikationer_i_pdf/2008/UK_Healthcare_in_dk/pdf.ashx. DanishAccessed July 24, 2013
- FrankLEpidemiology. When an entire country is a cohortScience20002872398239910766613
- GreeneFLPageDLFlemingIDAJCC Cancer Staging Manual6th edNew York, NYSpringer2002
- HelqvistLErichsenRGammelagerHQuality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of PatientsEur J Cancer Care (Engl)20122172272722510213
- DobieSABaldwinLMDominitzJACompletion of therapy by Medicare patients with stage III colon cancerJ Natl Cancer Inst20069861061916670386
- LundJLSturmerTHarlanLCIdentifying specific chemotherapeutic agents in medicare data: a validation studyMed Care201351e27e3422080337
- WarrenJLHarlanLCFaheyAUtility of the SEER-Medicare data to identify chemotherapy useMed Care200240IV55IV61
- LundJLStürmerTSanoffHKBrookhartASandlerRSWarrenJLDeterminants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patientsCancer20131192038204723512326
- MackCDGlynnRJBrookhartMACalendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapyPharmacoepidemiol Drug Saf20132281081823296544
- SanoffHKCarpenterWRFreburgerJComparison of adverse events during 5-fuorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysisCancer20121184309432022294436
- SanoffHKCarpenterWRMartinCFComparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancerJ Natl Cancer Inst201210421122722266473
- SanoffHKCarpenterWRSturmerTEffect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 yearsJ Clin Oncol2012302624263422665536
- National Cancer PlanCopenhagen, DenmarkNational Board of Health2004 Available from: http://www.sst.dk/publ/Publ2004/The_Nat_Cancer_Plan_02.pdfAccessed July 24, 2013
- National Board of HealthNational Cancer Plan II, Copenhagen, Denmark: National Board of Health, 2005Copenhagen, DenmarkNational Board of Health2004 Available from: http://www.sst.dk/publ/Publ2005/PLAN/kraeftplan2/KraeftplanII_UK/KraeftplanII_UK_med.pdfAccessed July 24, 2013
- OstenfeldEBFroslevTFriisSCompleteness of colon and rectal cancer staging in the Danish Cancer Registry, 2004–2009Clin Epidemiol20124Suppl 2333823115791